Novavax, Inc. (NVAX) reported that net loss for the third quarter was $7.53 million, or $0.08 per share, compared to a net loss of $7.84 million, or $0.12 per share, for the same period last year.
Loss from continuing operations was $7.53 million or $0.08 per share, narrower than $10.33 million or $0.16 per share in the prior year quarter.
Total revenues grew to $201 thousand from $194 thousand in the same quarter last year.
On average, 3 analysts polled by Thomson Reuters expected the company to report loss of $0.09 per share, on revenues of $30 thousand. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.